| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |